Tobias Larsson Agervald

Chairman & CEO

C-suiteM

FI·FIN-FSA

Guard Therapeutics International AB (publ)Guard Therapeutics International AB (publ)

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Explore the complete record of transactions filed by Tobias Larsson Agervald, Chairman & CEO. Director active across 2 companies, notably Guard Therapeutics International AB (publ). In total, 2 filings have been logged. The latest transaction was filed on 15 May 2025 (Purchase). Regulator: FIN-FSA. All data is free.

Declarations2 total

Executives●PurchaseGGuard Therapeutics International AB (publ)23FIN-FSA

T

Tobias Larsson AgervaldVerkställande direktör (VD)

0643,647 shares0

Option

FI:A003O454-1·15 May 2025

Ideal exit: 9 Feb 2026 (T+270)

FIN-FSA ↗

Executives●PurchaseGGuard Therapeutics International AB (publ)35FIN-FSA

T

Tobias Larsson AgervaldVerkställande direktör (VD)

€11,0957,872 shares@ €1.40940.041% mcap100.0% of flow

BTA (betald tecknad aktie)

FI:A003N203-1·4 Apr 2025

Ideal exit: 30 Dec 2025 (T+270)

FIN-FSA ↗

2 of 2 declarations

About Tobias Larsson Agervald

Tobias Larsson Agervald is the Chief Executive Officer of Guard Therapeutics International AB (publ). He leads the company with a strategic vision, focusing on innovation and treatment development. His role is essential for the growth of Guard Therapeutics, which specializes in innovative therapeutic solutions.